Emtora Biosciences
Commercializing eRapa™, a novel, targeted formulation of rapamycin, for the prevention of cancer progression/recurrence
San Antonio, United States
2 employees
Grant
Total: $23.83M
Biotechnology, Health Care +3
General Information
San Antonio, United States
BounceWatch is an independent company data service, not affiliated with Emtora Biosciences. To contact Emtora Biosciences, visit emtorabio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Emtora Biosciences compare?
A PDF of Emtora Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Emtora Biosciences soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Emtora Biosciences on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Emtora Biosciences
Business keywords: emerging biotech, cancer prevention, rapamycin, eRapa, clinical trials, pharmaceutical research, prostate cancer, age-related diseases, life science company, immunosuppressant, healthspan, lifespan extension, scientific breakthroughs, precision medicine, drug development
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $16.90M | 1 |
Cancer Prevention and Research Institute of Texas
|
19 Aug 2022 |
| Grant | $3.00M | 1 |
Cancer Prevention and Research Institute of Texas
|
22 Aug 2019 |
| Series A | $2.50M | - |
|
02 Jun 2015 |
| Debt Financing | $1.43M | - |
|
03 Feb 2014 |
| Convertible Note | Undisclosed | 1 |
|
09 Jul 2013 |
| Seed Round | Undisclosed | 1 |
|
01 Dec 2012 |
Emtora Biosciences Alternatives & Competitors
View All Alternatives
Developing therapeutics to reduce the risk and recurrence of cancer and other diseases.
Advancing Medicines for a Brighter Future
Preventing Adaptive Drug Resistance and Cancer Metastasis
FAQ About Emtora Biosciences
Source: BounceWatch company record for Emtora Biosciences, https://bouncewatch.com/company/emtora-biosciences, updated 28 October 2024. When citing, please name BounceWatch and link this page.
